FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

776876003: Natalizumab (product)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3734003011 Product containing only natalizumab (medicinal product) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3734004017 Natalizumab only product en Synonym Active Entire term case insensitive SNOMED CT core module
2827351000001112 Natalizumab (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom Edition module
2827361000001110 Natalizumab en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module


6 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Natalizumab Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Natalizumab Is a Product containing natalizumab true Inferred relationship Existential restriction modifier
Natalizumab Has active ingredient Natalizumab true Inferred relationship Existential restriction modifier 1
Natalizumab Is a Virtual therapeutic moiety true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only natalizumab in parenteral dose form (medicinal product form) Is a True Natalizumab Inferred relationship Existential restriction modifier
Natalizumab 150mg/1ml solution for injection pre-filled syringes Is a True Natalizumab Inferred relationship Existential restriction modifier
Natalizumab 300mg/15ml solution for infusion vials Is a True Natalizumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start